Sep 2026
Immunotherapy with Pembrolizumab beyond Progression and Local Ablative Therapy in Oligoprogressive metastatic NSCLC.
A. Oseledchyk, Leopold Haecker, A. Schmitt et al.
· Oncology Research and Treatm... · 0 citations